STOVADIS

This brand name is authorized in Cyprus

Active ingredients

The drug STOVADIS contains a combination of these active pharmaceutical ingredients (APIs):

1 Carvedilol
UNII 0K47UL67F2 - CARVEDILOL

Carvedilol is a vasodilatory non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha1-receptor blockade and suppresses the renin-angiotensin system through non-selective beta-blockade. Plasma renin activity is reduced and fluid retention is rare.

Read about Carvedilol
2 Ivabradine
UNII TP19837BZK - IVABRADINE HYDROCHLORIDE

Ivabradine is a pure heart rate lowering agent, acting by selective and specific inhibition of the cardiac pacemaker If current that controls the spontaneous diastolic depolarisation in the sinus node and regulates heart rate. The cardiac effects are specific to the sinus node with no effect on intra-atrial, atrioventricular or intraventricular conduction times, nor on myocardial contractility or ventricular repolarisation.

Read about Ivabradine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C07FX06 C Cardiovascular system → C07 Beta blocking agents → C07F Beta blocking agents and other antihypertensives → C07FX Beta blocking agents, other combinations
Discover more medicines within C07FX06

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.